Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations
- PMID: 31800099
- PMCID: PMC7318693
- DOI: 10.1002/jimd.12200
Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations
Abstract
The importance of protein glycosylation in regulating lipid metabolism is becoming increasingly apparent. We set out to further investigate this by studying the effects of defective glycosylation on plasma lipids in patients with B4GALT1-CDG, caused by a mutation in B4GALT1 with defective N-linked glycosylation. We studied plasma lipids, cholesteryl ester transfer protein (CETP) glyco-isoforms with isoelectric focusing followed by a western blot and CETP activity in three known B4GALT1-CDG patients and compared them with 11 age- and gender-matched, healthy controls. B4GALT1-CDG patients have significantly lowered non-high density lipoprotein cholesterol (HDL-c) and total cholesterol to HDL-c ratio compared with controls and larger HDL particles. Plasma CETP was hypoglycosylated and less active in B4GALT1-CDG patients compared to matched controls. Our study provides insight into the role of protein glycosylation in human lipoprotein homeostasis. The hypogalactosylated, hypo-active CETP found in patients with B4GALT1-CDG indicates a role of protein galactosylation in regulating plasma HDL and LDL. Patients with B4GALT1-CDG have large HDL particles probably due to hypogalactosylated, hypo-active CETP.
Keywords: B4GALT1; CDG; CETP; HDL; LDL; glycosylation; lipids.
© 2019 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.
Conflict of interest statement
The authors have declared that no conflict of interest exists.
Figures

References
-
- Funke S, Gardeitchik T, Kouwenberg D, et al. Perinatal and early infantile symptoms in congenital disorders of glycosylation. Am J Med Genet A. 2013;161:578‐584. - PubMed
-
- Jaeken J. Congenital disorders of glycosylation. Ann N Y Acad Sci. 2010;1214:190‐198. - PubMed
-
- van den Boogert M, Larsen LE, Ali L, et al. N‐glycosylation defects in humans lower low‐density lipoprotein cholesterol through increased low‐density lipoprotein receptor expression. Circulation. 2019;140:280‐292. - PubMed
-
- van den Boogert M, Rader DJ, Holleboom AG. New insights into the role of glycosylation in lipoprotein metabolism. Curr Opin Lipidol. 2017;28:502‐506. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical